GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.74B
1-Year Return
32.47%
This Quarter Return
+13.14%
1 Year Return
+32.47%
3 Year Return
+84.41%
5 Year Return
–
10 Year Return
–
AUM
$967M
AUM Growth
-$11.3M
(-1.2%)
Cap. Flow
-$94.7M
Cap. Flow
% of AUM
-9.79%
Top 10 Holdings %
Top 10 Hldgs %
49.41%
Holding
180
New
62
Increased
13
Reduced
11
Closed
61
Top Buys
| 1 |
Las Vegas Sands
LVS
|
$73.8M |
| 2 |
Corebridge Financial
CRBG
|
$65M |
| 3 |
Clearwater Analytics
CWAN
|
$14M |
| 4 |
Leonardo DRS
DRS
|
$13.8M |
| 5 |
Fluence Energy
FLNC
|
$11.9M |
Top Sells
| 1 |
Rollins
ROL
|
$93.3M |
| 2 |
AerCap
AER
|
$81.5M |
| 3 |
Enbridge
ENB
|
$56.7M |
| 4 |
JD.com
JD
|
$29.1M |
| 5 |
Core & Main
CNM
|
$28.9M |
Sector Composition
| 1 | Technology | 29.34% |
| 2 | Consumer Discretionary | 19.8% |
| 3 | Financials | 13.62% |
| 4 | Energy | 7.41% |
| 5 | Healthcare | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Resideo Technologies
REZI
$5.33B
| – | – |
-64,900
| Closed | -$1.03M |
|
152
RenaissanceRe
RNR
$11.4B
| – | – |
-50,000
| Closed | -$9.9M |
|
153
Roivant Sciences
ROIV
$8.73B
| – | – |
-400,000
| Closed | -$4.67M |
|
|
154
Rollins
ROL
$27.5B
| – | – |
-2,500,000
| Closed | -$93.3M |
|
155
Revolution Medicines
RVMD
$7.46B
| – | – |
-25,000
| Closed | -$692K |
|
|
SAFE
156
Safehold
SAFE
$1.17B
| – | – |
-100,000
| Closed | -$1.78M |
|
157
Sally Beauty Holdings
SBH
$1.41B
| – | – |
-93,972
| Closed | -$787K |
|
158
TD Synnex
SNX
$12.4B
| – | – |
-100,000
| Closed | -$9.99M |
|
159
Tarsus Pharmaceuticals
TARS
$2.41B
| – | – |
-50,000
| Closed | -$889K |
|
160
Tidewater
TDW
$2.86B
| – | – |
-50,000
| Closed | -$3.55M |
|
161
Treace Medical Concepts
TMCI
$461M
| – | – |
-25,000
| Closed | -$328K |
|
162
Terreno Realty
TRNO
$6.11B
| – | – |
-25,000
| Closed | -$1.42M |
|
163
Vertiv
VRT
$47B
| – | – |
-327,546
| Closed | -$12.2M |
|
164
VSE Corp
VSEC
$3.39B
| – | – |
-20,000
| Closed | -$1.01M |
|
165
Cactus
WHD
$2.96B
| – | – |
-25,000
| Closed | -$1.26M |
|
166
XP
XP
$9.91B
| – | – |
-603,500
| Closed | -$13.9M |
|
167
Zoom
ZM
$25.1B
| – | – |
-30,000
| Closed | -$2.1M |
|
168
Pacific Biosciences
PACB
$378M
| – | – |
-25,000
| Closed | -$209K |
|
169
Mineralys Therapeutics
MLYS
$2.28B
| – | – |
-10,000
| Closed | -$95.1K |
|
170
Madison Square Garden
MSGE
$1.95B
| – | – |
-150,000
| Closed | -$4.94M |
|
171
Navitas Semiconductor
NVTS
$1.19B
| – | – |
-125,000
| Closed | -$869K |
|
172
ONE Gas
OGS
$4.53B
| – | – |
-60,000
| Closed | -$4.1M |
|
173
Biomea Fusion
BMEA
$111M
| – | – |
-20,000
| Closed | -$275K |
|
|
FNA
174
DELISTED
Paragon 28, Inc.
FNA
| – | – |
-15,000
| Closed | -$188K |
|
|
SQSP
175
DELISTED
Squarespace, Inc.
SQSP
| – | – |
-135,000
| Closed | -$3.91M |
|